1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with sulfasalazine in 4 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (sulfasalazine) | Trials (sulfasalazine) | Recent Studies (post-2010) (sulfasalazine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 4,437 | 585 | 938 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | sulfasalazine (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 1.5 | |
| Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | 3 | |
| Carbonic anhydrase 1 | Homo sapiens (human) | 3.04 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 4.49 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 6.332 | |
| Sodium/bile acid cotransporter | Homo sapiens (human) | 9.6 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.46 | |
| Cystine/glutamate transporter | Homo sapiens (human) | 0.16 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.56 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eliakim, R; Karmeli, F; Ligumsky, M; Rachmilewitz, D; Simon, P | 1 |
| Eliakim, R; Karmeli, F; Rachmilewitz, D | 1 |
| Eliakim, R; Karmeli, F; Rachmilewitz, D; Razin, E | 1 |
| Gálvez, J; Garrido, M; Merlos, M; Torres, MI; Zarzuelo, A | 1 |
4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sulfasalazine
| Article | Year |
|---|---|
Cytokines and platelet-activating factor in human inflamed colonic mucosa.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anti-Idiotypic; Calcimycin; Colitis, Ulcerative; Colon; Crohn Disease; Humans; Imidazoles; Immunoglobulin E; Interleukin-1; Intestinal Mucosa; Mesalamine; Organ Culture Techniques; Platelet Activating Factor; Prednisolone; Sulfasalazine; Thiazoles | 1992 |
Platelet-activating factor--a possible mediator in the pathogenesis of ulcerative colitis.
Topics: Aminosalicylic Acids; Cells, Cultured; Colitis, Ulcerative; Dose-Response Relationship, Drug; Humans; Ionophores; Mesalamine; Platelet Activating Factor; Prednisolone; Sulfasalazine | 1990 |
Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone.
Topics: Adult; Aminosalicylic Acids; Calcimycin; Colitis, Ulcerative; Colon; Drug Combinations; Female; Glucosamine; Humans; Immunoglobulin E; Intestinal Mucosa; Male; Middle Aged; Platelet Activating Factor; Prednisolone; Rectum; Sulfapyridine; Sulfasalazine | 1988 |
Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat.
Topics: Acute Disease; Aminosalicylic Acids; Animals; Anti-Inflammatory Agents; Aza Compounds; Chronic Disease; Colitis; Colon; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gastrointestinal Agents; Intestinal Mucosa; Intestines; Male; Mesalamine; Platelet Activating Factor; Rabbits; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid | 2000 |